These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21763506)

  • 41. Influence of trypanocidal therapy on the haematology of vervet monkeys experimentally infected with Trypanosoma brucei rhodesiense.
    Ngotho M; Kagira JM; Kariuki C; Maina N; Thuita JK; Mwangangi DM; Farah IO; Hau J
    Acta Trop; 2011 Jul; 119(1):14-8. PubMed ID: 21420376
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of 10-day melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sickness.
    Schmid C; Nkunku S; Merolle A; Vounatsou P; Burri C
    Lancet; 2004 Aug 28-Sep 3; 364(9436):789-90. PubMed ID: 15337407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemotherapy against human African trypanosomiasis: is there a road to success?
    Burri C
    Parasitology; 2010 Dec; 137(14):1987-94. PubMed ID: 20961469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Veterinary link to drug resistance in human African trypanosomiasis?
    Barrett MP
    Lancet; 2001 Aug; 358(9282):603-4. PubMed ID: 11530144
    [No Abstract]   [Full Text] [Related]  

  • 45. Trypanosoma brucei rhodesiense: effect of immunosuppression on the efficacy of melarsoprol treatment of infected mice.
    Frommel TO
    Exp Parasitol; 1988 Dec; 67(2):364-6. PubMed ID: 3191962
    [No Abstract]   [Full Text] [Related]  

  • 46. Virus replication begins in dendritic cells during the transmission of HIV-1 from mature dendritic cells to T cells.
    Granelli-Piperno A; Finkel V; Delgado E; Steinman RM
    Curr Biol; 1999 Jan; 9(1):21-9. PubMed ID: 9889121
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HIV-1 subtype variability in Vif derived from molecular clones affects APOBEC3G-mediated host restriction.
    Lisovsky I; Schader SM; Sloan RD; Oliveira M; Coutsinos D; Bernard NF; Wainberg MA
    Intervirology; 2013; 56(4):258-64. PubMed ID: 23689841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dendritic cells derived from hemozoin-loaded monocytes display a partial maturation phenotype that promotes HIV-1 trans-infection of CD4+ T cells and virus replication.
    Diou J; Tardif MR; Barat C; Tremblay MJ
    J Immunol; 2010 Mar; 184(6):2899-907. PubMed ID: 20147629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The interferon-induced expression of APOBEC3G in human blood-brain barrier exerts a potent intrinsic immunity to block HIV-1 entry to central nervous system.
    Argyris EG; Acheampong E; Wang F; Huang J; Chen K; Mukhtar M; Zhang H
    Virology; 2007 Oct; 367(2):440-51. PubMed ID: 17631933
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.
    Chiu YL; Soros VB; Kreisberg JF; Stopak K; Yonemoto W; Greene WC
    Nature; 2005 May; 435(7038):108-14. PubMed ID: 15829920
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reversal of the sleep/wake cycle disorder of sleeping sickness after trypanosomicide treatment.
    Buguet A; Tapie P; Bert J
    J Sleep Res; 1999 Sep; 8(3):225-35. PubMed ID: 10476010
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short communication: Nitazoxanide inhibits HIV viral replication in monocyte-derived macrophages.
    Gekonge B; Bardin MC; Montaner LJ
    AIDS Res Hum Retroviruses; 2015 Feb; 31(2):237-41. PubMed ID: 25303025
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Topical chemotherapy for experimental murine African CNS-trypanosomiasis: the successful use of the arsenical, melarsoprol, combined with the 5-nitroimidazoles, fexinidazole or MK-436.
    Jennings FW; Atouguia JM; Murray M
    Trop Med Int Health; 1996 Oct; 1(5):590-8. PubMed ID: 8911443
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression.
    Peng G; Greenwell-Wild T; Nares S; Jin W; Lei KJ; Rangel ZG; Munson PJ; Wahl SM
    Blood; 2007 Jul; 110(1):393-400. PubMed ID: 17371941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Arsenic, selenium, and African trypanosomiasis.
    Golden MH
    Lancet; 1992 Jun; 339(8806):1413. PubMed ID: 1350819
    [No Abstract]   [Full Text] [Related]  

  • 56. Mel B in the treatment of tryparsamide resistant T. gambiense sleeping sickness: observations on drug resistance in the trypanosomes of the French Cameroun.
    FRIEDHEIM EA
    Am J Trop Med Hyg; 1951 Mar; 31(2):218-35. PubMed ID: 14819516
    [No Abstract]   [Full Text] [Related]  

  • 57. Metalloprotease TRABD2A Restriction of HIV-1 Production in Monocyte-Derived Dendritic Cells.
    Liu M; Dong J; Ouyang J; Zhao L; Liang G; Shang H
    AIDS Res Hum Retroviruses; 2019 Oct; 35(10):887-889. PubMed ID: 31282173
    [No Abstract]   [Full Text] [Related]  

  • 58. Efficient inhibition of HIV-1 replication in human immature monocyte-derived dendritic cells by purified anti-HIV-1 IgG without induction of maturation.
    Holl V; Peressin M; Schmidt S; Decoville T; Zolla-Pazner S; Aubertin AM; Moog C
    Blood; 2006 Jun; 107(11):4466-74. PubMed ID: 16469871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [African trypanosomiasis, virus disease, Mel B and encephalitis].
    JANSSENS PG; VAN BOGAERT L; MICHIELS A; VAN DE STEEN R
    Ann Soc Belg Med Trop (1920); 1960 Oct; 40():759-69. PubMed ID: 13789507
    [No Abstract]   [Full Text] [Related]  

  • 60. Immunopathological and chemotherapeutic studies in experimental trypanosomiasis with special reference to the heart and brain.
    Poltera AA
    Trans R Soc Trop Med Hyg; 1980; 74(6):706-15. PubMed ID: 7210124
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.